GURUGRAM — In a medical case that has sent ripples through the Indian healthcare community, a 10-year-old girl in the Delhi NCR region has been diagnosed with chronic pancreatitis, a debilitating condition traditionally associated with decades of alcohol or tobacco use in adults. The diagnosis, confirmed on March 31, 2026, by specialists at the Fortis Memorial Research Institute, serves as a stark reminder of the changing landscape of pediatric health in India, where non-communicable diseases (NCDs) once reserved for the elderly are increasingly appearing in the young.
The young patient had suffered from debilitating abdominal pain, persistent vomiting, and unexplained weight loss for nearly two years before receiving a definitive diagnosis. By the time she reached specialists, the prolonged inflammation had already caused significant scarring and permanent damage to her pancreas, triggering early-onset diabetes—a severe complication for a child of her age.
A Precision Intervention
Under the leadership of Dr. Amit Javed, Principal Director and Head of Gastrointestinal Surgery at Fortis, a multidisciplinary team determined that the girl’s pancreatic ducts were severely blocked. When standard medications failed to provide relief, the team opted for a sophisticated surgical intervention.
“By the time she came to us, the disease had already significantly affected the pancreas,” Dr. Javed explained. “If untreated, it can permanently impact nutrition, growth, and blood sugar control.”
The surgical team performed a laparoscopic lateral pancreaticojejunostomy, a minimally invasive procedure designed to drain the blocked ducts and relieve the intense internal pressure. The results were transformative. Within weeks, the patient reported a complete cessation of pain, a restored appetite, and significant weight gain, allowing her to return to school for the first time in months.
Understanding Chronic Pancreatitis: Not Just an Adult Ailment
The pancreas is a vital organ located behind the stomach, responsible for producing enzymes that digest food and insulin that regulates blood sugar. Chronic pancreatitis involves a continuous, irreversible inflammation that leads to the replacement of healthy tissue with scar tissue.
In adults, lifestyle factors like heavy drinking or smoking are primary triggers. However, in children, the etiology is vastly different. According to the INSPPIRE study (International Study Group of Pediatric Pancreatitis: In Search for a Cure), genetic mutations—specifically in the PRSS1 or SPINK1 genes—account for up to 73% of pediatric cases.
In India, the disease profile presents unique challenges. Research published in the International Journal of Contemporary Pediatrics indicates that in certain regions, such as Karnataka, over 90% of pediatric cases are “idiopathic,” meaning the cause remains unknown even after investigation. Despite the lack of a clear cause, nearly half of these children show calcific changes (stone formation) on scans, indicating advanced disease.
Why Are We Seeing More Cases?
While chronic pancreatitis remains rare, affecting roughly 0.5 per 100,000 people annually, its prevalence in specialized pediatric gastroenterology centers in India has been noted as high as 2.5%. Experts suggest this may not necessarily mean the disease is “new,” but rather that we are finally getting better at finding it.
Dr. Sufla Saxena, a Pediatric Gastroenterologist at Manipal Hospitals Dwarka, emphasizes that early symptoms are often misread. “Symptoms like pain after eating or nausea are frequently dismissed as simple indigestion or ‘tummy troubles,'” Dr. Saxena noted. “For families with a history of pancreatic issues or recurrent pain, genetic testing is key to early detection.”
The rise in cases also mirrors a broader, more concerning trend: a doubling of pediatric non-communicable diseases among Indian youth aged 5–17 over the last decade. This surge is attributed to a complex interplay of genetic predisposition, environmental factors, and shifting lifestyles.
Challenges in Diagnosis and Long-Term Outlook
The road to recovery for pediatric patients is often hindered by a “diagnostic lag.” Because many primary care physicians do not expect to see chronic pancreatitis in a child, patients may go through years of ineffective treatments for irritable bowel syndrome (IBS) or infections.
Dr. Anupam Sibal, Senior Consultant at Indraprastha Apollo Hospital, warns that delays can be catastrophic. “With over 25 years in pediatric GI, I’ve seen genetic pancreatitis rise. Prompt imaging is essential to prevent the irreversible damage that leads to lifelong insulin dependence or malnutrition.”
Current Treatment Statistics for Pediatric CP:
-
Pain Relief: Surgery yields an 83–90% success rate in long-term pain management.
-
Complications: Only 4.8% of children in studied cohorts developed diabetes post-surgery.
-
Success Rates: 90.5% of treated children in recent Indian studies remained symptom-free at follow-up.
The Way Forward: A Call for Vigilance
The implications for public health are significant. Children with chronic pancreatitis face risks of growth stunting and exocrine pancreatic insufficiency (the inability to digest food properly).
Public health advocates are now calling for increased awareness among parents and educators. If a child suffers from recurrent, severe upper abdominal pain that radiates to the back, or exhibits “greasy” stools and weight loss, a consultation with a pediatric gastroenterologist is vital.
While the surgical success in Gurugram offers hope, experts stress that the medical community must expand access to genetic testing and minimally invasive surgical techniques. As pediatric disease patterns evolve, the “adult” label on chronic illnesses is rapidly becoming a relic of the past.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.